{"nct_id":"NCT02614183","title":"Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2015-11-30","start_date_type":"ACTUAL","primary_completion_date":"2017-03-22","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}